{"database": "lobbying", "table": "lobbying_activities", "rows": [[995404, "01102a71-dcb7-4c0a-a036-d3fa314a7316", "Q3", "THE NORMANDY GROUP, LLC", 306636, "GENENTECH", 2010, "third_quarter", "CPT", "Monitor legislation regarding brand name and generic pharmaceutical agreements, patent fees, and post-grant review reforms.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2010-10-15T16:34:01.200000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["995404"], "units": {}, "query_ms": 13.272566022351384, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}